A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors

✍ Scribed by A. S. T. Planting; P. Sonneveld; A. van der Gaast; A. Sparreboom; M. E. L. van der Burg; G. P. M. Luyten; K. de Leeuw; M. de Boer-Dennert; P. S. Wissel; R. C. Jewell; E. M. Paul; N. B. Purvis; J. Verweij

• Publisher: Springer
• Year: 2004
• Tongue: English
• Weight: 253 KB
• Volume: 55
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-004-0854-6